These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 2962263
1. [20 years after the discovery of the Australia antigen]. Grob PJ. Schweiz Rundsch Med Prax; 1987 Dec 08; 76(50):1402-6. PubMed ID: 2962263 [No Abstract] [Full Text] [Related]
3. Hepatitis B: a scientific success story (almost). Purcell RH. Prog Clin Biol Res; 1985 Oct 08; 182():11-43. PubMed ID: 3162171 [No Abstract] [Full Text] [Related]
4. [The Public Health Council refines the selection process for (re)vaccination against hepatitis B]. Sekhuis J. Ned Tijdschr Geneeskd; 1987 Apr 11; 131(15):618-20. PubMed ID: 2952890 [No Abstract] [Full Text] [Related]
5. [Australia-antigen 25 years later]. Ring-Larsen H. Ugeskr Laeger; 1998 Jan 19; 160(4):399-400. PubMed ID: 9463249 [No Abstract] [Full Text] [Related]
6. [Infection by hepatitis B virus and its prevention]. Kashiwagi S. Rinsho Byori; 1987 Jan 19; 35(1):9-16. PubMed ID: 3560486 [No Abstract] [Full Text] [Related]
7. Prevention of hepatitis B by recombinant DNA hepatitis B vaccine. Schalm SW, Heijtink RA. Neth J Med; 1986 Jan 19; 29(2):42-8. PubMed ID: 3951652 [No Abstract] [Full Text] [Related]
8. Recombinant yeast hepatitis B vaccine. Hilleman MR. Dev Biol Stand; 1986 Jan 19; 63():57-62. PubMed ID: 3527821 [No Abstract] [Full Text] [Related]
9. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century. Yap SF. Malays J Pathol; 2004 Jun 19; 26(1):1-12. PubMed ID: 16190102 [Abstract] [Full Text] [Related]
14. Significance of pre-S2 peptide of hepatitis B virus: should it be in the vaccine? Hellström UB, Sylvan SP. Prog Med Virol; 1988 Feb 13; 35():76-106. PubMed ID: 2971987 [No Abstract] [Full Text] [Related]
15. [The discovery of the "Australia antigen". An important stage in the knowledge of viral hepatitis]. Fauvert R. Rein Foie; 1970 Feb 13; 13():Suppl B:9+. PubMed ID: 4928937 [No Abstract] [Full Text] [Related]
17. [Response to vaccination against the etiologic agent of viral hepatitis B (HBV) in a population at risk]. Lavezzi M, Donati A, Davi D, Carpanelli MC, Farinelli S, Soracco E. Quad Sclavo Diagn; 1987 Jun 13; 23(2):164-8. PubMed ID: 2967519 [Abstract] [Full Text] [Related]
18. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Lauchart W, Müller R, Pichlmayr R. Transplant Proc; 1987 Feb 13; 19(1 Pt 3):2387-9. PubMed ID: 2978894 [No Abstract] [Full Text] [Related]